IL-18 DNA Injection Helps Fight Liver Cancer in Mice
Author Information
Author(s): Chang Chi-Young, Lee Jienny, Kim Eun-Young, Park Hae-Jung, Kwon Choon-Hyuck, Joh Jae-Won, Kim Sung-Joo
Primary Institution: Samsung Medical Center, Sungkyunkwan University School of Medicine
Hypothesis
Does intratumoral delivery of IL-18 plasmid DNA enhance T-cell activation and Th1 response in a mouse model of hepatic cancer?
Conclusion
Direct plasmid DNA transfer of IL-18 may be a useful approach in tumor immunotherapy.
Supporting Evidence
- IL-18 plasmid injection led to a significant increase in immune cell populations.
- Tumor growth was significantly lower in mice treated with IL-18 compared to control.
- Increased levels of IFN-γ were observed in splenocytes from IL-18 treated mice.
Takeaway
Injecting a special DNA into tumors can help the body's immune system fight cancer better.
Methodology
Mice with liver tumors received injections of IL-18 plasmid DNA, and tumor growth and immune responses were measured over time.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
BALB/c mice, 6 to 8 weeks old.
Statistical Information
P-Value
0.006
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website